Published :
Tables : 45
Figures : 43
Category : Healthcare
No. of Pages : 220
Report Code : HC-1174
Biomaterials Market is anticipated to register a CAGR of 6% during the forecast period 2022 to 2028. FutureWise Market Research has instantiated a report that provides an intricate analysis of Biomaterials Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Biomaterials Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Biomaterials are a vital part of the medical industry. Most of biomaterials are medical implants for therapeutic or diagnostic purposes. Catheters, cardiac valves, ligaments, scaffolds and so on are examples of commonly used biomaterials. The new research in medical implants, increasing cases of cardiovascular and orthopedic diseases across the globe, targeted drug delivery, etc. are driving factors for the growth of the market. Furthermore, the advances in diagnostic research related to biomaterials has driven its preference by end users. The natural biomaterials have a variety of applications based on the material used like silk, collagen, fibrin, etc..The targeted delivery by collagen fibers is the key factor for the demand of natural biomaterials. Currently, the biomaterial scaffolds that are used to modulate cancer are in trend. Rising cancer risk and awareness are anticipated drivers for natural biomaterials demand. Based on applications, the rising population of the cardiac and orthopedic patients dominates the growth of the market. There is a widespread availability of products for treatment and the expenses spent on them contribute to a large market share of biomaterials across the globe. North America dominates the global market due to the increasing incidences of cardiovascular diseases in the region. Asia Pacific region has a large population across the globe and also the risk of adopting cardiovascular and other diseases. This boosts the market of biomaterials in the Asia Pacific region. Major players included in the Biomaterials Market: • Basf Se • Covestro Ag • Celanese Corporation • Carpenter Technology Corporation • Royal Dsm • Corbion • Evonik Industries • Victrex Plc • Ceramtec Gmbh • Mitsubishi Chemical Holdings Corporation (Advansource Biomaterials Corp.) • Coorstek Inc • Berkeley Advanced Biomaterials • Cam Bioceramics B.v. • Zeus Industrial Products, Inc. • Gelita Ag • Rdi Group (Collagen Solutions Plc) • Riton Biomaterial Co., Ltd. • Artoss, Inc. • Nobel Biomaterials • Dimension Inx (Note: The list of the major players will be updated with the latest market scenario and trends Biomaterials Market Segmentation: By Type • Metallic Biomaterials o Stainless Steel o Titanium & Titanium Alloys o Cobalt-chrome Alloys o Gold o Silver o Magnesium • Polymeric Biomaterials o Polymethylmethacrylate (Pmma) o Polyethylene o Polyester o Polyvinylchloride o Silicone Rubber o Nylon o Polyetheretherketone o Other Polymeric Biomaterials • Ceramic Biomaterials o Calcium Phosphate o Zirconia o Aluminum Oxide o Calcium Sulfate o Carbon o Glass • Natural Biomaterials o Hyaluronic Acid o Collagen o Gelatin o Fibrin o Cellulose o Chitin o Alginates o Silk By Application • Cardiovascular o Catheters o Stents o Implantable Cardiac Defibrillators o Pacemakers o Sensors o Heart Valves o Vascular Grafts o Guidewires o Other Products • Orthopedic o Joint Replacement • Knee Replacement • Hip Replacement • Shoulder Replacement • Other Joint Replacement Applications o Viscosupplementation o Bioresorbable Tissue Fixation • Suture Anchors • Interference Screws • Meniscal Repair Tacks • Meshes o Spine • Spinal Fusion • Minimally Invasive Fusion • Motion Preservation & Dynamic Stabilization o Pedicle-based Rod Systems o Interspinous Spacers o Artificial Discs o Fracture Fixation Devices • Bone Plates • Screws • Pins • Rods • Wires o Synthetics Bone Grafts • Ophthalmology o Contact Lenses o Intraocular Lenses o Functional Replacement Of Ocular Tissues o Synthetic Corneas o Other Ophthalmology Applications • Dental o Dental Implants o Dental Bone Grafts & Substitutes o Dental Membranes o Tissue Regeneration Materials • Plastic Surgery o Soft-tissue Fillers o Craniofacial Surgery • Wound Healing o Wound Closure Devices • Sutures • Staples o Surgical Hemostats o Internal Tissue Sealants o Adhesion Barriers o Hernia Meshes • Tissue Engineering o Scaffolds For Regenerative Medicine o Nanomaterials For Biosensing o Tailoring Of Inorganic Nanoparticles • Neurological/central Nervous System Applications o Shunting Systems o Cortical Neural Prosthetics o Hydrogel Scaffolds For Cns Repair o Neural Stem Cell Encapsulation • Other Applications o Drug Delivery Systems o Gastrointestinal Applications o Bariatric Surgery o Urinary Applications By Region • North America • Europe • Asia Pacific • Latin America • Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market Laboratories and Agilent Technologies, Inc. with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Investment in cardiac and orthopedic biomaterials marketing Focus on natural biomaterials research Objectives of the Study: To provide with an exhaustive analysis on the biomaterials market by type, by application and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization services offered are free of charge with purchase of any license of the report. You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Biomaterials Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Biomaterials Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Biomaterials are a vital part of the medical industry. Most of biomaterials are medical implants for therapeutic or diagnostic purposes. Catheters, cardiac valves, ligaments, scaffolds and so on are examples of commonly used biomaterials.
The new research in medical implants, increasing cases of cardiovascular and orthopedic diseases across the globe, targeted drug delivery, etc. are driving factors for the growth of the market. Furthermore, the advances in diagnostic research related to biomaterials has driven its preference by end users.
The natural biomaterials have a variety of applications based on the material used like silk, collagen, fibrin, etc..The targeted delivery by collagen fibers is the key factor for the demand of natural biomaterials. Currently, the biomaterial scaffolds that are used to modulate cancer are in trend. Rising cancer risk and awareness are anticipated drivers for natural biomaterials demand.
Based on applications, the rising population of the cardiac and orthopedic patients dominates the growth of the market. There is a widespread availability of products for treatment and the expenses spent on them contribute to a large market share of biomaterials across the globe.
North America dominates the global market due to the increasing incidences of cardiovascular diseases in the region. Asia Pacific region has a large population across the globe and also the risk of adopting cardiovascular and other diseases. This boosts the market of biomaterials in the Asia Pacific region.
Major players included in the Biomaterials Market: • Basf Se • Covestro Ag • Celanese Corporation • Carpenter Technology Corporation • Royal Dsm • Corbion • Evonik Industries • Victrex Plc • Ceramtec Gmbh • Mitsubishi Chemical Holdings Corporation (Advansource Biomaterials Corp.) • Coorstek Inc • Berkeley Advanced Biomaterials • Cam Bioceramics B.v. • Zeus Industrial Products, Inc. • Gelita Ag • Rdi Group (Collagen Solutions Plc) • Riton Biomaterial Co., Ltd. • Artoss, Inc. • Nobel Biomaterials • Dimension Inx (Note: The list of the major players will be updated with the latest market scenario and trends
Biomaterials Market Segmentation: By Type • Metallic Biomaterials o Stainless Steel o Titanium & Titanium Alloys o Cobalt-chrome Alloys o Gold o Silver o Magnesium • Polymeric Biomaterials o Polymethylmethacrylate (Pmma) o Polyethylene o Polyester o Polyvinylchloride o Silicone Rubber o Nylon o Polyetheretherketone o Other Polymeric Biomaterials • Ceramic Biomaterials o Calcium Phosphate o Zirconia o Aluminum Oxide o Calcium Sulfate o Carbon o Glass • Natural Biomaterials o Hyaluronic Acid o Collagen o Gelatin o Fibrin o Cellulose o Chitin o Alginates o Silk By Application • Cardiovascular o Catheters o Stents o Implantable Cardiac Defibrillators o Pacemakers o Sensors o Heart Valves o Vascular Grafts o Guidewires o Other Products • Orthopedic o Joint Replacement • Knee Replacement • Hip Replacement • Shoulder Replacement • Other Joint Replacement Applications o Viscosupplementation o Bioresorbable Tissue Fixation • Suture Anchors • Interference Screws • Meniscal Repair Tacks • Meshes o Spine • Spinal Fusion • Minimally Invasive Fusion • Motion Preservation & Dynamic Stabilization o Pedicle-based Rod Systems o Interspinous Spacers o Artificial Discs o Fracture Fixation Devices • Bone Plates • Screws • Pins • Rods • Wires o Synthetics Bone Grafts • Ophthalmology o Contact Lenses o Intraocular Lenses o Functional Replacement Of Ocular Tissues o Synthetic Corneas o Other Ophthalmology Applications • Dental o Dental Implants o Dental Bone Grafts & Substitutes o Dental Membranes o Tissue Regeneration Materials • Plastic Surgery o Soft-tissue Fillers o Craniofacial Surgery • Wound Healing o Wound Closure Devices • Sutures • Staples o Surgical Hemostats o Internal Tissue Sealants o Adhesion Barriers o Hernia Meshes • Tissue Engineering o Scaffolds For Regenerative Medicine o Nanomaterials For Biosensing o Tailoring Of Inorganic Nanoparticles • Neurological/central Nervous System Applications o Shunting Systems o Cortical Neural Prosthetics o Hydrogel Scaffolds For Cns Repair o Neural Stem Cell Encapsulation • Other Applications o Drug Delivery Systems o Gastrointestinal Applications o Bariatric Surgery o Urinary Applications By Region • North America • Europe • Asia Pacific • Latin America • Middle East and Africa
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Biomaterials Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biomaterials Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Biomaterials Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Biomaterials Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Metallic Biomaterials 7.1.1 Stainless Steel 7.1.2 Titanium & Titanium Alloys 7.1.3 Cobalt-chrome Alloys 7.1.4 Gold 7.1.5 Silver 7.1.6 Magnesium 7.2. Polymeric Biomaterials 7.2.1 Polymethylmethacrylate (Pmma) 7.2.2 Polyethylene 7.2.3 Polyester 7.2.4 Polyvinylchloride 7.2.5 Silicone Rubber 7.2.6 Nylon 7.2.7 Polyetheretherketone 7.2.8 Other Polymeric Biomaterials 7.3. Ceramic Biomaterials 7.3.1 Calcium Phosphate 7.3.2 Zirconia 7.3.3 Aluminum Oxide 7.3.4 Calcium Sulfate 7.3.5 Carbon 7.3.6 Glass 7.4. Natural Biomaterials 7.4.1 Hyaluronic Acid 7.4.2 Collagen 7.4.3 Gelatin 7.4.4 Fibrin 7.4.5 Cellulose 7.4.6 Chitin 7.4.7 Alginates 7.4.8 Silk 8. Biomaterials Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Cardiovascular 8.1.1. Catheters 8.1.2. Stents 8.1.3. Implantable Cardiac Defibrillators 8.1.4. Pacemakers 8.1.5. Sensors 8.1.6. Heart Valves 8.1.7. Vascular Grafts 8.1.8. Guidewires 8.1.9. Other Products 8.2. Orthopedic 8.2.1. Joint Replacement 8.2.1.1. Knee Replacement 8.2.1.2. Hip Replacement 8.2.1.3. Shoulder Replacement 8.2.1.4. Other Joint Replacement Applications 8.2.2. Viscosupplementation 8.2.3. Bioresorbable Tissue Fixation 8.2.3.1. Suture Anchors 8.2.3.2. Interference Screws 8.2.3.3. Meniscal Repair Tacks 8.2.3.4. Meshes 8.2.4. Spine 8.2.4.1. Spinal Fusion 8.2.4.2. Minimally Invasive Fusion 8.2.4.3. Motion Preservation & Dynamic Stabilization 8.2.4.3.1. Pedicle-based Rod Systems 8.2.4.3.2. Interspinous Spacers 8.2.4.3.3. Artificial Discs 8.2.5. Fracture Fixation Devices 8.2.5.1. Bone Plates 8.2.5.2. Screws 8.2.5.3. Pins 8.2.5.4. Rods 8.2.5.5. Wires 8.2.6. Synthetics Bone Grafts 8.3. Ophthalmology 8.3.1. Contact Lenses 8.3.1.1. Intraocular Lenses 8.3.1.2. Functional Replacement Of Ocular Tissues 8.3.1.3. Synthetic Corneas 8.3.1.4. Other Ophthalmology Applications 8.4. Dental 8.4.1. Dental Implants 8.4.2. Dental Bone Grafts & Substitutes 8.4.3. Dental Membranes 8.4.4. Tissue Regeneration Materials 8.5. Plastic Surgery 8.5.1. Soft-tissue Fillers 8.5.2. Craniofacial Surgery 8.6. Wound Healing 8.6.1. Wound Closure Devices 8.6.1.1. Sutures 8.6.1.2. Staples 8.6.2. Surgical Hemostats 8.6.3. Internal Tissue Sealants 8.6.4. Adhesion Barriers 8.6.5. Hernia Meshes 8.7. Tissue Engineering 8.7.1. Scaffolds For Regenerative Medicine 8.7.2. Nanomaterials For Biosensing 8.7.3. Tailoring Of Inorganic Nanoparticles 8.8. Neurological/central Nervous System Applications 8.8.1. Shunting Systems 8.8.2. Cortical Neural Prosthetics 8.8.3. Hydrogel Scaffolds For Cns Repair 8.8.4. Neural Stem Cell Encapsulation 8.9. Other Applications 8.9.1. Drug Delivery Systems 8.9.2. Gastrointestinal Applications 8.9.3. Bariatric Surgery 8.9.4. Urinary Applications 9. North America Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028 10. Latin America Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028 11. Europe Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028 12. Asia Pacific Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Basf Se 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Covestro Ag 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Celanese Corporation 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Carpenter Technology Corporation. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Royal Dsm 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Corbion 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Evonik Industries 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Victrex Plc 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Ceramtec Gmbh 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Mitsubishi Chemical Holdings Corporation (Advansource Biomaterials Corp.) 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Coorstek Inc 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Berkeley Advanced Biomaterials 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Cam Bioceramics B.v. 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Zeus Industrial Products, Inc. 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15. Gelita Ag 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16. Rdi Group (Collagen Solutions Plc) 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17. Riton Biomaterial Co., Ltd. 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18. Artoss, Inc. 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19. Nobel Biomaterials 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 15.20. Dimension Inx 15.20.1. Company Overview 15.20.2. Product Portfolio 15.20.3. SWOT Analysis 15.20.4. Financial Overview 15.20.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Biomaterials Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biomaterials Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Biomaterials Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Biomaterials Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Metallic Biomaterials 7.1.1 Stainless Steel 7.1.2 Titanium & Titanium Alloys 7.1.3 Cobalt-chrome Alloys 7.1.4 Gold 7.1.5 Silver 7.1.6 Magnesium 7.2. Polymeric Biomaterials 7.2.1 Polymethylmethacrylate (Pmma) 7.2.2 Polyethylene 7.2.3 Polyester 7.2.4 Polyvinylchloride 7.2.5 Silicone Rubber 7.2.6 Nylon 7.2.7 Polyetheretherketone 7.2.8 Other Polymeric Biomaterials 7.3. Ceramic Biomaterials 7.3.1 Calcium Phosphate 7.3.2 Zirconia 7.3.3 Aluminum Oxide 7.3.4 Calcium Sulfate 7.3.5 Carbon 7.3.6 Glass 7.4. Natural Biomaterials 7.4.1 Hyaluronic Acid 7.4.2 Collagen 7.4.3 Gelatin 7.4.4 Fibrin 7.4.5 Cellulose 7.4.6 Chitin 7.4.7 Alginates 7.4.8 Silk
8. Biomaterials Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Cardiovascular 8.1.1. Catheters 8.1.2. Stents 8.1.3. Implantable Cardiac Defibrillators 8.1.4. Pacemakers 8.1.5. Sensors 8.1.6. Heart Valves 8.1.7. Vascular Grafts 8.1.8. Guidewires 8.1.9. Other Products 8.2. Orthopedic 8.2.1. Joint Replacement 8.2.1.1. Knee Replacement 8.2.1.2. Hip Replacement 8.2.1.3. Shoulder Replacement 8.2.1.4. Other Joint Replacement Applications 8.2.2. Viscosupplementation 8.2.3. Bioresorbable Tissue Fixation 8.2.3.1. Suture Anchors 8.2.3.2. Interference Screws 8.2.3.3. Meniscal Repair Tacks 8.2.3.4. Meshes 8.2.4. Spine 8.2.4.1. Spinal Fusion 8.2.4.2. Minimally Invasive Fusion 8.2.4.3. Motion Preservation & Dynamic Stabilization 8.2.4.3.1. Pedicle-based Rod Systems 8.2.4.3.2. Interspinous Spacers 8.2.4.3.3. Artificial Discs 8.2.5. Fracture Fixation Devices 8.2.5.1. Bone Plates 8.2.5.2. Screws 8.2.5.3. Pins 8.2.5.4. Rods 8.2.5.5. Wires 8.2.6. Synthetics Bone Grafts 8.3. Ophthalmology 8.3.1. Contact Lenses 8.3.1.1. Intraocular Lenses 8.3.1.2. Functional Replacement Of Ocular Tissues 8.3.1.3. Synthetic Corneas 8.3.1.4. Other Ophthalmology Applications 8.4. Dental 8.4.1. Dental Implants 8.4.2. Dental Bone Grafts & Substitutes 8.4.3. Dental Membranes 8.4.4. Tissue Regeneration Materials 8.5. Plastic Surgery 8.5.1. Soft-tissue Fillers 8.5.2. Craniofacial Surgery 8.6. Wound Healing 8.6.1. Wound Closure Devices 8.6.1.1. Sutures 8.6.1.2. Staples 8.6.2. Surgical Hemostats 8.6.3. Internal Tissue Sealants 8.6.4. Adhesion Barriers 8.6.5. Hernia Meshes 8.7. Tissue Engineering 8.7.1. Scaffolds For Regenerative Medicine 8.7.2. Nanomaterials For Biosensing 8.7.3. Tailoring Of Inorganic Nanoparticles 8.8. Neurological/central Nervous System Applications 8.8.1. Shunting Systems 8.8.2. Cortical Neural Prosthetics 8.8.3. Hydrogel Scaffolds For Cns Repair 8.8.4. Neural Stem Cell Encapsulation 8.9. Other Applications 8.9.1. Drug Delivery Systems 8.9.2. Gastrointestinal Applications 8.9.3. Bariatric Surgery 8.9.4. Urinary Applications
9. North America Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028
10. Latin America Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028
11. Europe Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028
12. Asia Pacific Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Basf Se 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Covestro Ag 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Celanese Corporation 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Carpenter Technology Corporation. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Royal Dsm 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Corbion 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Evonik Industries 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Victrex Plc 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Ceramtec Gmbh 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Mitsubishi Chemical Holdings Corporation (Advansource Biomaterials Corp.) 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Coorstek Inc 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Berkeley Advanced Biomaterials 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Cam Bioceramics B.v. 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Zeus Industrial Products, Inc. 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15. Gelita Ag 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16. Rdi Group (Collagen Solutions Plc) 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17. Riton Biomaterial Co., Ltd. 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18. Artoss, Inc. 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19. Nobel Biomaterials 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 15.20. Dimension Inx 15.20.1. Company Overview 15.20.2. Product Portfolio 15.20.3. SWOT Analysis 15.20.4. Financial Overview 15.20.5. Strategic Overview
16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics